SEC Form 4 · accession 0001209191-15-010883
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Lynn Roberts
Officer — Sr VP Finance & Administrat
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.16 | Feb 5, 2015 | A | 43,000 | A | — | Feb 4, 2025 | Common Stock | 43,000 | 163,774 | D |
Explanation of responses
- F1This option was granted on February 5, 2015. The option vests as to 2.08333% of the underlying shares monthly through and including February 5, 2019.